NASDAQ · Analyst Forecast

Ionis Pharmaceuticals, Inc. (IONS) Stock Forecast & Price Target

$26.96 NASDAQ: IONS Market Cap $4.49B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Ionis Pharmaceuticals, Inc. (IONS), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Ionis Pharmaceuticals, Inc., analysts forecast revenue rising from $900.07M in 2025 to $2.60B in 2030; the average estimate for 2030 earnings per share is $3.59; with published estimates ranging from $2.55 to $5.25; 19 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$26.96
Consensus targetThe average of the price targets analysts have published.$81.00
Median targetThe middle target, less affected by a single outlier.$85.00
Highest targetThe most optimistic published target.$115.00
Lowest targetThe most pessimistic published target.$54.00
Difference from priceHow far the consensus target sits from today’s price.+200.4%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$885.94M$900.07M$918.51M13
2026$891.89M$921.99M$998.38M18
2027$977.51M$1.17B$1.35B19
2028$1.16B$1.64B$2.25B18
2029$1.63B$2.10B$2.85B10
2030$2.02B$2.60B$3.52B11

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$2.59−$2.28−$1.9513
2026−$3.55−$3.48−$3.4518
2027−$4.18−$2.84−$1.8019
2028−$18.82−$0.53$17.8718
2029$1.12$1.57$2.3010
2030$2.55$3.59$5.2511

Ionis Pharmaceuticals, Inc. (IONS) forecast — frequently asked questions

What is the analyst price target for Ionis Pharmaceuticals, Inc.?

Analysts covering Ionis Pharmaceuticals, Inc. (IONS) have a consensus price target of $81.00, 200.4% above the current price of $26.96. Published targets range from $54.00 to $115.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Ionis Pharmaceuticals, Inc.'s earnings?

The average analyst estimate for Ionis Pharmaceuticals, Inc. (IONS) earnings per share in 2030 is 3.59, with individual estimates between 2.55 and 5.25.

How much revenue is Ionis Pharmaceuticals, Inc. expected to make?

Analysts forecast Ionis Pharmaceuticals, Inc. (IONS) revenue of $2.60B in 2030, based on 11 published estimates.

How many analysts cover IONS?

19 analysts contribute estimates for Ionis Pharmaceuticals, Inc. (IONS). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.